Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
杰富瑞
JEF
5
亚马逊
AMZN
加拿大市场个股详情
PFE Pfizer CDR (CAD Hedged)
- 10.980
- +0.350+3.29%
延时15分钟行情已收盘 04/29 15:59 (美东)
1833.79亿总市值15.94市盈率TTM
11.090最高价10.370最低价24.85万股成交量10.560今开10.630昨收270.81万成交额14.26952周最高0.00%换手率167.01亿总股本9.68052周最低0.689每股收益TTM621.67亿流通值26.478历史最高15.94市盈率(静)56.62亿流通股9.680历史最低0.689每股收益(静)6.77%振幅0.82股息TTM1.50市净率1股每手7.43%股息率TTM
关于Pfizer CDR (CAD Hedged)公司
辉瑞是全球最大的制药公司之一，年销售额接近500亿美元（不包括与新冠相关的产品销售额）。虽然其历史上曾销售过多种医疗保健产品和化学品，但现在处方药和疫苗占据了绝大多数销售额。畅销的产品包括肺炎球菌疫苗Prevnar 13、抗癌药物Ibrance和心血管治疗药物Eliquis。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。在国际销售中，新兴市场是主要贡献者。
公司介绍
公司代码PFE
公司名称Pfizer CDR (CAD Hedged)
成立日期1942
所属市场NEOE
员工数量81000
年结日12-31
公司地址66 Hudson Boulevard East
城市New York
国家美国
邮编10001-2192
电话+1 212 733-2323
董事高管
- 姓名
- 职务
- 年薪
- Dr. Albert Bourla, D.V.M.,PhD
- Chairman of the Board and Chief Executive Officer
- 2464.87万
- Sally Susman
- Chief Corporate Affairs Officer and Executive Vice President
- --
- Payal Sahni
- Chief People Experience Officer and Executive Vice President
- --
- Lidia L. Fonseca
- Executive Vice President, Chief Digital and Technology Officer
- --
- Michael McDermott
- Executive Vice President, Chief Global Supply and Quality Officer
- --
- Douglas M. Lankler
- Chief Legal Officer and Executive Vice President
- --
- David M. Denton
- Chief Financial Officer and Executive Vice President
- 812.45万
- Alexandre de Germay
- Chief International Commercial Officer and Executive Vice President
- --
- Aamir Malik
- Chief U.S. Commercial Officer and Executive Vice President
- 829.43万
- Dr. Chris Boshoff, M.D.,PhD
- Chief Scientific Officer and President, Research and Development
- 785.40万
- Dr. Andrew Baum, M.D.
- Executive Vice President, Chief Strategy and Innovation Officer
- --
- Jennifer B. Damico
- Principal Accounting Officer, Senior Vice President and Controller
- --
- Margaret M. Madden
- Senior Vice President, Corporate Secretary and Chief Governance Counsel
- --
- Suzanne Nora Johnson
- Independent Director
- 41.00万
- Shantanu Narayen
- Lead Independent Director
- 44.50万
- Ronald E. Blaylock
- Independent Director
- 36.00万
- Mortimer J. Buckley
- Independent Director
- 14.56万
- Joseph J. Echevarria
- Independent Director
- 39.00万
- James Robert Quincey
- Independent Director
- 38.00万
- James C. Smith
- Independent Director
- 39.00万
- Cyrus Taraporevala
- Independent Director
- 26.88万
- Dr. Susan J. Hockfield, PhD
- Independent Director
- 36.30万
- Dr. Susan D. Desmond-Hellmann, M.D.,M.P.H.
- Independent Director
- 36.00万
- Dr. Scott Gottlieb,M.D.
- Independent Director
- 39.00万
- Dr. Dan R. Littman, M.D.,PhD
- Independent Director
- 38.00万
热门市场机会
热门讨论
2025巴菲特股东大会：价值投资将掀何新潮？
🎙️讨论 1. 面对市场变化，你更倾向于坚守成长股还是转向价值股？ 2. 基于当前市场形势，你认为巴菲特未来会重点布局哪些行业或领域？ 3. 针对伯克希尔·哈撒韦的未来投资策略，你会如何调整自己的投资组合？
Moomoo News Global
04/28 18:10
沃伦·巴菲特在美国股票下跌时依然坚挺：'神谕者'如何应对关税影响